<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Conroy AL</submitter><funding>Kim Kertland; the Tesari Foundation</funding><funding>Canada Research Chair in Molecular Parasitology</funding><funding>Canada Research Chair in Infectious Diseases and Inflammation</funding><funding>Sandra Rotman Centre for Global Health</funding><funding>Canadian Institutes of Health Research</funding><pagination>ofw134</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5047396</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>3(3)</volume><pubmed_abstract>&lt;b>&lt;i>Background.&lt;/i>&lt;/b>  Host responses to infection are critical determinants of disease severity and clinical outcome. The development of tools to risk stratify children with malaria is needed to identify children most likely to benefit from targeted interventions. &lt;b>&lt;i>Methods.&lt;/i>&lt;/b>  This study investigated the kinetics of candidate biomarkers of mortality associated with endothelial activation and dysfunction (angiopoietin-2 [Ang-2], soluble FMS-like tyrosine kinase-1 [sFlt-1], and soluble intercellular adhesion molecule-1 [sICAM-1]) and inflammation (10 kDa interferon γ-induced protein [CXCL10/IP-10] and soluble triggering receptor expressed on myeloid cells-1 [sTREM-1]) in the context of a randomized, double-blind, placebo-controlled, parallel-arm trial evaluating inhaled nitri</pubmed_abstract><journal>Open forum infectious diseases</journal><pubmed_title>Host Biomarkers Are Associated With Response to Therapy and Long-Term Mortality in Pediatric Severe Malaria.</pubmed_title><pmcid>PMC5047396</pmcid><funding_grant_id>MOP-115160</funding_grant_id><funding_grant_id>-13721</funding_grant_id><funding_grant_id>-136813</funding_grant_id><pubmed_authors>McDonald CR</pubmed_authors><pubmed_authors>Conroy AL</pubmed_authors><pubmed_authors>Kim H</pubmed_authors><pubmed_authors>Barker KR</pubmed_authors><pubmed_authors>John CC</pubmed_authors><pubmed_authors>Opoka RO</pubmed_authors><pubmed_authors>Liles WC</pubmed_authors><pubmed_authors>Higgins SJ</pubmed_authors><pubmed_authors>Namasopo S</pubmed_authors><pubmed_authors>Hawkes M</pubmed_authors><pubmed_authors>Kain KC</pubmed_authors></additional><is_claimable>false</is_claimable><name>Host Biomarkers Are Associated With Response to Therapy and Long-Term Mortality in Pediatric Severe Malaria.</name><description>&lt;b>&lt;i>Background.&lt;/i>&lt;/b>  Host responses to infection are critical determinants of disease severity and clinical outcome. The development of tools to risk stratify children with malaria is needed to identify children most likely to benefit from targeted interventions. &lt;b>&lt;i>Methods.&lt;/i>&lt;/b>  This study investigated the kinetics of candidate biomarkers of mortality associated with endothelial activation and dysfunction (angiopoietin-2 [Ang-2], soluble FMS-like tyrosine kinase-1 [sFlt-1], and soluble intercellular adhesion molecule-1 [sICAM-1]) and inflammation (10 kDa interferon γ-induced protein [CXCL10/IP-10] and soluble triggering receptor expressed on myeloid cells-1 [sTREM-1]) in the context of a randomized, double-blind, placebo-controlled, parallel-arm trial evaluating inhaled nitri</description><dates><release>2016-01-01T00:00:00Z</release><publication>2016 Sep</publication><modification>2026-04-30T19:14:51.208Z</modification><creation>2019-03-27T02:25:42Z</creation></dates><accession>S-EPMC5047396</accession><cross_references><pubmed>27703996</pubmed><doi>10.1093/ofid/ofw134</doi></cross_references></HashMap>